Monsanto ruling brings comfort for biotech, but decision limited
This article was originally published in Scrip
Executive Summary
While the Supreme Court's ruling this week in favor of agra giant Monsanto involving patent protection of its Roundup Ready seeds was a good turn of events for the biotechnology community at large, the court made a point that its decision was limited to that one case – leaving open the door that questions about other lawsuits involving self-replicating inventions might come before the justices.